San Diego-centered Viking Therapeutics marked by itself as a significant competitor in the weight loss drug marketplace in February after revealing promising facts from the mid-phase demo of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when supplied to be a weekly injection As well as in March the c